5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 63, Issue 4, 1996, Pages 610-614

  Ou, C Y ^a   Stevenson, R E ^b   Brown, V K ^a   Schwartz, C E ^b   Allen, W P ^b   Khoury, M J ^a   Rozen, R ^c   Oakley Jr , G P ^a   Adams Jr , M J ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b GREENWOOD GENETIC CENTER   (United States)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Anencephaly; Encephalocele; Folic acid; Methylenetetrahydrofolate reductase; Neural tube defects; Spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ANENCEPHALUS; ARTICLE; DNA POLYMORPHISM; ENCEPHALOCELE; FETUS; FIBROBLAST CULTURE; GENOTYPE; HUMAN; HUMAN CELL; NEURAL TUBE DEFECT; PRIORITY JOURNAL; SPINA BIFIDA;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADULT; AFRICAN AMERICANS; ALLELES; ANENCEPHALY; ENZYME STABILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FETUS; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MOLECULAR SEQUENCE DATA; NEURAL TUBE DEFECTS; OXIDOREDUCTASES; POLYMORPHISM, GENETIC; RISK FACTORS; SPINAL DYSRAPHISM;

EID: 0030018760     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L     Document Type: Article

References (13)

1. →T mutation, and the role of folate. Lancet 346; 1703.
2. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995): A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111-113.
3. Goyette P, Summer JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, Rozen R (1994): Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nature Genet 7:195-200.
4. Jacques PF, Bostrom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996): Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
5. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N (1991): Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545.
6. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G (1988): Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414-421.
7. Mills JL, McPartin JM, Kirke PN, Lee YL, Conley MR, Weir DG, Scott JM (1995): Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
8. Posey DL, Khoury MJ, Mulinare J, Adams MJ Jr, Ou CY (1996): Is mutated methylenetetrahydrofolate reductase (MTHFR) a risk factor for neural tube defects? A pooled analysis. Lancet 347:686-687.
9. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, Thomas CMG, Nijhuis JG, Borm GF, Eskes TK (1995): Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172:1436-1441.
10. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters GAJ, Eskes TKAB (1994): Maternal hyperhomocysteinemia: A risk factor for neural-tube defects? Metabolism 43:1475-1480.
11. van der Put N, Steegers-Theunissen R, Frosst P, Trijbels F, Eskes TKAB, van den Heuvel LP, Mariman E, den Heyer M, Rozen R, Blom H (1995): Mutated 5,10 methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-71.
12. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Shields DC, Scott JM (1995): A genetic defect in 5,10 methylenetetrahydrafolate reductase in neural tube defects. Q J Med 88:763-766.
13. U.S. Public Health Service (1992): Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41:1-7.